Guy P. Nohra, Director at Carbylan Therapeutics, Inc. (CBYL), bought 1,605,090 shares at $5.00 ($4.4M) on 2015-04-14, disclosed to the SEC on 2015-04-14.
Open-market purchase of $4.4M CBYL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 727,590 | $0 | 0.0% |
| 2 | $5.00 | 877,500 | $4.4M | 100.0% |
| Total | $2.73 avg | 1,605,090 | $4.4M | 100% |
| Filing → |
| ALLK | SELL | 2020-06-19 | $1.1M | — | Filing → |
| NEOT | BUY | 2014-11-25 | $980K | — | Filing → |
| NEOT | SELL | 2014-11-25 | $2.1M | — | Filing → |